Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02682199 · ClinicalTrials.gov registry record
Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation
A clinical trial of Xerostomia, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT02682199 is a study of Xerostomia that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 100 participants, above the 88-participant average among 13 other Xerostomia trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02682199, a study of Xerostomia, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this prospective observational study is to investigate whether whole brain radiation leads to measurable xerostomia from parotid gland toxicity.
Conditions Studied
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill, Department of Radiation Oncology - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02682199
The ClinicalTrials.gov registry entry for NCT02682199 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 88-participant average among 13 other Xerostomia trials with a reported enrollment target (14% higher). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Xerostomia appearing as the primary indexed condition, and to 0 interventions.
NCT02682199 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02682199 about?
NCT02682199 is a clinical study titled "Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation". The goal of this prospective observational study is to investigate whether whole brain radiation leads to measurable xerostomia from parotid gland toxicity.
What is the current status of trial NCT02682199?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-10. Estimated completion is 2018-08-30.
What conditions does trial NCT02682199 study?
This clinical trial studies the following conditions: Xerostomia.
Who is sponsoring clinical trial NCT02682199?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02682199 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Xerostomia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC
RECRUITING · Phase 1
-
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
RECRUITING · Phase 1
-
Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy
ACTIVE NOT RECRUITING · Phase 1
-
Effect of Whitening Agent With Emulsion Gel in Saliva and Halitosis
ACTIVE NOT RECRUITING · NA
-
Observational Study of Dental Outcomes in Head and Neck Cancer Patients
ACTIVE NOT RECRUITING
-
Dry Mouth Toothpaste Study - Comparing Two Toothpastes With Arginine
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.